Plasmodium falciparum: Sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 4, 1997, Pages 468-472

  Smithuis, F M ^a,e   Monti, F ^a   Grundl, M ^a   Zaw Oo, A ^b   Kyaw, T T ^b   Phe, O ^b   White, N J ^c,d  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Vector Borne Disease Control   (Myanmar)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNICEF   (United States)

Author keywords

Chemotherapy; Chloroquine; Drug resistance; Malaria; Mefloquine; Myanmar; Plasmodium falciparum; Pyrimethamine sulfadoxine

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR; MEFLOQUINE;

ADOLESCENT; AGE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MYANMAR; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; TREATMENT FAILURE;

PLASMODIUM FALCIPARUM;

EID: 0030751387     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90288-1     Document Type: Article

References (15)

1. Kwiatkowski, D. & Bate, C. (1995). Inhibition of tumour necrosis factor (TNF) production by antimalarial drugs used in cerebral malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 215-216.
2. Looareesuwan, S., Phillips, R. E., White, N. J., Karbwang, J., Benjasurat, Y., Attanath, P. & Warrell, D. A. (1985). Intravenous amodiaquine and oral amodiaquine/erythromycin in the treatment of chloroquine-resistant falciparum malaria. Lancet, ii, 805-808.
3. Nosten, F., Luxemburger, C., ter Kuile, F. O., Woodrow, C., Pa Eh, J., Chongsuphajaisiddhi, T. & White, N. J. (1994). Optimum artesunate-mefloquine combination for the treatment of multi-drug resistant Plasmodium falciparum malaria. Journal of Infectious Diseases, 170, 971-977.
4. Olliaro, P., Nevill, C., Le Bras, J., Ringwald, P., Mussano, P., Garner, P. & Brasseur, P. (1996). Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet, 348, 1196-1201.
5. Onyiorah, E., van Hensbroek, M. B., Jah, M. S. & Greenwood, B. (1996). Early clinical failures after pyrimethamine/sulfadoxine treatment of uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 307-308.
6. Price, R. N., Nosten, F., Luxemburger, C., ter Kuile, F., Paiphun, L., Chongsuphajaisiddhi, T. & White, N. J. (1996). The effects of artemisinin derivatives on malaria transmissability. Lancet, 347, 1654-1658.
7. Shiff, C., Checkley, W., Winch, P., Premji, Z., Minjas, J. & Lubega, P. (1996). Changes in weight gain and anaemia attributable to malaria in Tanzanian children living under holoendemic conditions. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 262-265.
8. Ter Kuile, F., White, N. J., Holloway, P., Pasvol, G. & Krishna, S. (1993). Plasmodium falciparum: in-vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Experimental Parasitology, 76, 86-95.
9. Tin, F. & Hlaing, N. (1984). Comparative drug trial of a sulfadoxine/pyrimethamine and a sulfalene/pyrimethamine combination against Plasmodium falciparum infections in semi-immune populations of Burma. Southeast Asian Journal of Tropical Medicine and Public Health, 15, 238-248.
10. Tin, F., Hlaing, N. & Lasserre, R. (1982). Single-dose treatment of falciparum malaria with mefloquine: field studies with different doses in semi-immune adults and children in Burma. Bulletin of the World Health Organization, 60, 913-917.
11. Watt, G., Long, G. W., Padre, L., Alban, P., Sangalang, R., Ranoa, C. P. & Laughlin, L.W. (1987). Amodiaquine less effective than chloroquine in the treatment of falciparum malaria in the Philippines. American Journal of Tropical Medicine and Hygiene, 36, 3-8.
12. White, N. J. (1992). Antimalarial drug resistance: the pace quickens. Journal of Antimicrobial Agents and Chemotherapy, 30, 571-585.
13. WHO (1973). Chemotherapy of Malaria and Resistance to Anti-malarials. Geneva: World Health Organization, Technical Report Series, no. 529.
14. WHO (1990). Severe and complicated malaria, 2nd edition. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, supplement 2.
15. WHO (1994). Antimalarial drug policies: data requirements, treatment of uncomplicated malaria and management of malaria in pregnancy. Report of an informal consultation. Geneva: World Health Organization, mimeographed document WHO/MAL/94.1070.